The Convergent Science Cancer Consortium, a consortium using an unconventional approach that emphasizes the integration of diverse scientific disciplines, received a $3.2 million grant from the U.S. Department of Defense.
A trio of research papers from Stanford Medicine researchers and their international collaborators transforms scientists’ understanding of how small DNA circles—until recently, dismissed as inconsequential—are major drivers of many types of human cancers.
